Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | Gut Pathogens

Fig. 1

From: Amelioration of intestinal and systemic sequelae of murine Campylobacter jejuni infection by probiotic VSL#3 treatment

Fig. 1

Kinetic of intestinal probiotic bacterial and/or C. jejuni strain 81–176 loads in perorally associated secondary abiotic mice. Secondary abiotic mice were generated by broad-spectrum antibiotic treatment and perorally re-associated with a the probiotic compound VSL#3 (white symbols) on day (d) 0, b C. jejuni strain 81–176 (Cj; black symbols) on d0, c VSL#3 on day 0 and C. jejuni strain 81–176 on d5 or d C. jejuni strain 81–176 (d0) and VSL#3 on d0 as described in “Methods”. Bacterial colonization densities were assessed in fecal samples (CFU/g, colony forming units per gram) over time upon re-association as indicated by culture. Medians (black bars) and levels of significance (p value) determined by Mann–Whitney U test are indicated. Numbers of analyzed mice are given in parentheses. Data were pooled from three independent experiments. N.d. not determined

Back to article page